Basit öğe kaydını göster

dc.contributor.authorHuddam, Bülent
dc.contributor.authorÖztürk, Savaş
dc.contributor.authorTurgutalp, Kenan
dc.contributor.authorArıcı, Mustafa
dc.contributor.authorGörgülü, Numan
dc.date.accessioned2022-04-01T11:18:19Z
dc.date.available2022-04-01T11:18:19Z
dc.date.issued2022en_US
dc.identifier.citationOzturk S, Turgutalp K, Arici M, Gorgulu N, Tonbul HZ, Eren N, Gencer V, Ayli MD, Pembegul İ, Dolarslan ME, Ural Z, Colak H, Ozler TE, Can O, Demir ME, Altunoren O, Huddam B, Onec K, Demirelli B, Aydin Z, Altun E, Alagoz S, Ayar Y, Eser ZE, Berktas B, Yilmaz Z, Ates EU, Yuksel E, Sahin GK, Aktar M, Cebeci E, Dursun B, Kocak SY, Yildiz A, Kazan S, Gok M, Sengul E, Tugcu M, Ozturk R, Kahvecioglu S, Kara E, Kaya B, Sahin G, Sakaci T, Sipahi S, Kurultak İ, Durak BA, Altiparmak MR, Ecder SA, Karadag S, Dincer MT, Ozer H, Bek SG, Ulu MS, Gungor O, Bakir EA, Odabas AR, Seyahi N, Yildiz A, Ates K. The Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkey. Kidney Int Rep. 2022 Mar 25. doi: 10.1016/j.ekir.2022.03.017. Epub ahead of print. PMID: 35350104; PMCID: PMC8949692en_US
dc.identifier.urihttps://doi.org/10.1016/j.ekir.2022.03.017
dc.identifier.urihttps://hdl.handle.net/20.500.12809/9894
dc.description.abstractBackground: Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively. Methods: We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19. A control HD group without COVID-19 was selected from patients in the same center. We investigated the characteristics and outcomes in the follow-up of HD patients and compare them with the non-COVID group. Results: A total of 1223 patients (635 patients in COVID-19 group, 588 patients in non-COVID group) from 47 centers were included in the study. The patients' baseline and HD characteristics were almost similar. 28th day mortality and mortality between 28th day-90th day were higher in the COVID-19 group than non-COVID group [19 (3.0%) patients vs. none (0%); 15 (2.4%) patients vs. 4 (0.7%) patients, respectively]. The presence of respiratory symptoms, rehospitalization, need for home oxygen therapy, lower respiratory tract infection, A-V fistula thrombosis were significantly higher in the COVID-19 group in both the first 28 days and between 28-90 days. In the multivariable analysis, age [Odds ratio (OR) (95% confidence interval[CI]): 1.029(1.004-1.056)], group (COVID-19 group vs. non-COVID group) [OR (95%CI): 7.258(2.538-20.751) and vascular access type (tunneled catheter/AV fistula) [OR(95%CI): 2.512 (1.249-5.051)] were found as independent parameters related to 90-day mortality. Conclusion: In the post-COVID period, maintenance HD patients who have had COVID-19 have increased rehospitalization, respiratory problems, vascular access problems, and high mortality compared to the non-COVID HD patients.en_US
dc.item-language.isoengen_US
dc.publisherELSEVIERen_US
dc.relation.isversionof10.1016/j.ekir.2022.03.017en_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectHemodialysisen_US
dc.subjectNationwide studyen_US
dc.subjectOutcomeen_US
dc.titleThe Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkeyen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.authorID0000-0002-8412-1584en_US
dc.contributor.institutionauthorHuddam, Bülent
dc.relation.journalKidney International Reportsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster